ocrelizumab cost
Recombinant humanized antibody expressed in CHO binding to human MS4A1/CD20. Ocrelizumab is a humanized anti-CD20 monoclonal antibody. It targets mature B lymphocytes and hence is an immunosuppressive drug candidate. It had reached Phase III clinical trials for rheumatoid arthritis and lupus erythematosus, and Phase II for multiple scleros is and hematological cancer.
37 Sophia partners guarantee credit transfer.
299 Institutions have accepted or given pre-approval for credit transfer.
* The American Council on Education's College Credit Recommendation Service (ACE Credit®) has evaluated and recommended college credit for 33 of Sophia’s online courses. Many different colleges and universities consider ACE CREDIT recommendations in determining the applicability to their course and degree programs.
Free Professional Development